Free Trial

NewGenIvf Group (NIVF) Competitors

$0.35 +0.03 (+10.79%)
As of 01/17/2025 03:59 PM Eastern

NIVF vs. MRAI, BRTX, KDLY, OTRK, BGLC, MGRX, ATIP, ATPC, DHAC, and VSEE

Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Ontrak (OTRK), BioNexus Gene Lab (BGLC), Mangoceuticals (MGRX), ATI Physical Therapy (ATIP), Agape ATP (ATPC), Digital Health Acquisition (DHAC), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry.

NewGenIvf Group vs.

NewGenIvf Group (NASDAQ:NIVF) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Marpai has a consensus target price of $6.00, suggesting a potential upside of 488.24%. Given Marpai's stronger consensus rating and higher probable upside, analysts plainly believe Marpai is more favorable than NewGenIvf Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NewGenIvf Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Marpai
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Marpai received 2 more outperform votes than NewGenIvf Group when rated by MarketBeat users.

CompanyUnderperformOutperform
NewGenIvf GroupN/AN/A
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

In the previous week, NewGenIvf Group had 1 more articles in the media than Marpai. MarketBeat recorded 1 mentions for NewGenIvf Group and 0 mentions for Marpai. NewGenIvf Group's average media sentiment score of 0.70 beat Marpai's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the media.

Company Overall Sentiment
NewGenIvf Group Positive
Marpai Neutral

66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 49.8% of Marpai shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by company insiders. Comparatively, 61.3% of Marpai shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

NewGenIvf Group has a beta of -0.24, suggesting that its share price is 124% less volatile than the S&P 500. Comparatively, Marpai has a beta of 5.03, suggesting that its share price is 403% more volatile than the S&P 500.

NewGenIvf Group has a net margin of 0.00% compared to Marpai's net margin of -85.70%.

Company Net Margins Return on Equity Return on Assets
NewGenIvf GroupN/A N/A N/A
Marpai -85.70%N/A -100.23%

NewGenIvf Group has higher earnings, but lower revenue than Marpai.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewGenIvf Group$5.14M0.69$130KN/AN/A
Marpai$37.15M0.39-$28.75M-$2.64-0.39

Summary

NewGenIvf Group and Marpai tied by winning 7 of the 14 factors compared between the two stocks.

Get NewGenIvf Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NIVF vs. The Competition

MetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$3.54M$2.16B$5.34B$9.12B
Dividend YieldN/A8.00%5.37%4.01%
P/E RatioN/A11.9657.4613.13
Price / Sales0.697.531,272.2275.82
Price / Cash9.8510.5236.6632.72
Price / Book3.173.154.884.58
Net Income$130,000.00$65.07M$118.05M$224.83M
7 Day Performance5.76%2.49%1.45%2.37%
1 Month Performance4.77%8.74%2.50%4.40%
1 Year PerformanceN/A-16.52%25.79%20.10%

NewGenIvf Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NIVF
NewGenIvf Group
1.4811 of 5 stars
$0.35
+10.8%
N/AN/A$3.54M$5.14M0.00N/ANews Coverage
MRAI
Marpai
N/A$1.02
-1.0%
$6.00
+488.2%
-12.1%$14.02M$37.15M-0.39150Gap Down
BRTX
BioRestorative Therapies
3.9412 of 5 stars
$1.97
-3.0%
$18.00
+813.7%
+25.5%$13.63M$150,000.00-1.297Positive News
Gap Up
High Trading Volume
KDLY
Kindly MD
N/A$1.47
+1.6%
N/AN/A$8.81MN/A0.00N/APositive News
Gap Down
OTRK
Ontrak
2.6671 of 5 stars
$1.75
+0.6%
$45.00
+2,471.4%
-54.5%$7.39M$12.74M-0.16250
BGLC
BioNexus Gene Lab
0.2902 of 5 stars
$0.38
-0.7%
N/A-26.0%$6.78M$9.77M0.0030Gap Up
MGRX
Mangoceuticals
N/A$2.61
-2.6%
N/A-96.4%$6.50M$730,000.00-0.453Positive News
ATIP
ATI Physical Therapy
N/A$1.24
-29.1%
N/A-80.3%$5.47M$699.02M-0.075,600High Trading Volume
ATPC
Agape ATP
0.2016 of 5 stars
$1.33
+3.9%
N/A-85.9%$5.31M$1.43M-1.8240Gap Up
DHAC
Digital Health Acquisition
N/A$1.47
+4.3%
N/A-88.1%$5.30MN/A0.002,021
VSEE
Vsee Health
N/A$1.47
+4.3%
N/AN/A$5.29MN/A0.00N/APositive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:NIVF) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners